{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-151276","form_type":"8-K","ticker":"FULC","cik":"0001680581","company_name":"Fulcrum Therapeutics, Inc.","filed_at":"2025-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.316779+00:00","generated_at":"2026-05-18T16:04:10.510712+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Fulcrum Therapeutics 2025 annual meeting passes director elections, say-on-pay, auditor ratification","bullets":["Class III directors Katina Dorton, Robert Gould, and Kate Haviland elected with 44.6M, 43.8M, and 33.2M votes for, respectively.","Non-binding say-on-pay resolution approved with 46.1M votes for (99.8% of votes cast excluding broker non-votes).","Stockholders selected one year as frequency of future say-on-pay votes (44.9M votes for one year).","Ernst & Young LLP ratified as independent auditor for FY2025 with 49.5M votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-151276","json":"https://secwatch.observer/filing/0001193125-25-151276.json","markdown":"https://secwatch.observer/filing/0001193125-25-151276.md","text":"https://secwatch.observer/filing/0001193125-25-151276.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680581/000119312525151276/0001193125-25-151276-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680581/000119312525151276/d916678d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T16:04:10.510712+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}